ATE503489T1 - Behandlung von akutem nierenversagen mit löslichem thrombomodulin - Google Patents
Behandlung von akutem nierenversagen mit löslichem thrombomodulinInfo
- Publication number
- ATE503489T1 ATE503489T1 AT06825898T AT06825898T ATE503489T1 AT E503489 T1 ATE503489 T1 AT E503489T1 AT 06825898 T AT06825898 T AT 06825898T AT 06825898 T AT06825898 T AT 06825898T AT E503489 T1 ATE503489 T1 AT E503489T1
- Authority
- AT
- Austria
- Prior art keywords
- soluble thrombomodulin
- renal failure
- acute renal
- treatment
- thrombomodulin
- Prior art date
Links
- 102000012607 Thrombomodulin Human genes 0.000 title abstract 3
- 108010079274 Thrombomodulin Proteins 0.000 title abstract 3
- 208000009304 Acute Kidney Injury Diseases 0.000 title abstract 2
- 208000033626 Renal failure acute Diseases 0.000 title abstract 2
- 201000011040 acute kidney failure Diseases 0.000 title abstract 2
- 208000012998 acute renal failure Diseases 0.000 title abstract 2
- 208000037816 tissue injury Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72637605P | 2005-10-13 | 2005-10-13 | |
| PCT/US2006/040069 WO2007047430A2 (en) | 2005-10-13 | 2006-10-12 | Method of treating acute failure with thrombomodulin variant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE503489T1 true ATE503489T1 (de) | 2011-04-15 |
Family
ID=37670944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06825898T ATE503489T1 (de) | 2005-10-13 | 2006-10-12 | Behandlung von akutem nierenversagen mit löslichem thrombomodulin |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20080255047A1 (de) |
| EP (1) | EP1948216B1 (de) |
| JP (1) | JP5405829B2 (de) |
| AT (1) | ATE503489T1 (de) |
| CA (1) | CA2625888C (de) |
| CY (1) | CY1112438T1 (de) |
| DE (1) | DE602006021048D1 (de) |
| DK (1) | DK1948216T3 (de) |
| ES (1) | ES2360610T3 (de) |
| PL (1) | PL1948216T3 (de) |
| PT (1) | PT1948216E (de) |
| SI (1) | SI1948216T1 (de) |
| WO (1) | WO2007047430A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008073884A2 (en) * | 2006-12-12 | 2008-06-19 | Eli Lilly And Company | Treating acute renal failure with soluble thrombomodulin variants |
| WO2010056472A2 (en) * | 2008-11-12 | 2010-05-20 | Eli Lilly And Company | Compositions and methods of use for thrombomodulin variants |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2022713A1 (en) * | 1989-08-11 | 1991-02-12 | Nils U. Bang | Human thrombomodulin derivatives |
| DE69333491T2 (de) * | 1992-02-05 | 2005-03-31 | Paion Gmbh | Protease-Resistant Thrombomodulin Analogs |
| ATE249234T1 (de) * | 1993-12-17 | 2003-09-15 | Mochida Pharm Co Ltd | Lösliches thrombomodulin enthaltende zubereitung |
| CA2515916A1 (en) * | 2003-02-25 | 2004-09-10 | Biovec B.V. | Therapeutic applications of thrombomodulin gene via viral and non-viral vectors |
-
2006
- 2006-10-12 PL PL06825898T patent/PL1948216T3/pl unknown
- 2006-10-12 AT AT06825898T patent/ATE503489T1/de active
- 2006-10-12 CA CA2625888A patent/CA2625888C/en not_active Expired - Fee Related
- 2006-10-12 US US12/088,564 patent/US20080255047A1/en not_active Abandoned
- 2006-10-12 WO PCT/US2006/040069 patent/WO2007047430A2/en not_active Ceased
- 2006-10-12 EP EP06825898A patent/EP1948216B1/de not_active Not-in-force
- 2006-10-12 SI SI200631016T patent/SI1948216T1/sl unknown
- 2006-10-12 ES ES06825898T patent/ES2360610T3/es active Active
- 2006-10-12 DK DK06825898.7T patent/DK1948216T3/da active
- 2006-10-12 DE DE602006021048T patent/DE602006021048D1/de active Active
- 2006-10-12 JP JP2008535706A patent/JP5405829B2/ja not_active Expired - Fee Related
- 2006-10-12 PT PT06825898T patent/PT1948216E/pt unknown
-
2011
- 2011-05-13 CY CY20111100452T patent/CY1112438T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2625888A1 (en) | 2007-04-26 |
| CA2625888C (en) | 2015-09-22 |
| PL1948216T3 (pl) | 2011-10-31 |
| ES2360610T3 (es) | 2011-06-07 |
| WO2007047430A8 (en) | 2008-04-10 |
| EP1948216B1 (de) | 2011-03-30 |
| WO2007047430A3 (en) | 2007-05-24 |
| PT1948216E (pt) | 2011-05-06 |
| JP2009511597A (ja) | 2009-03-19 |
| JP5405829B2 (ja) | 2014-02-05 |
| EP1948216A2 (de) | 2008-07-30 |
| CY1112438T1 (el) | 2015-12-09 |
| SI1948216T1 (sl) | 2011-07-29 |
| US20080255047A1 (en) | 2008-10-16 |
| DE602006021048D1 (de) | 2011-05-12 |
| WO2007047430A2 (en) | 2007-04-26 |
| DK1948216T3 (da) | 2011-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1116160T1 (el) | Θεραπεια παιδιατρικης οξειας λεμφοβλαστικης λευχαιμιας | |
| AR109605A2 (es) | Método para tratar enfermedades vasculares periféricas, composición y utilización | |
| BR0308928A (pt) | Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular | |
| CY1117656T1 (el) | Επιλογες θεραπειας για τη νοσο του fabry | |
| HRP20110969T1 (en) | Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure | |
| NO20074943L (no) | Roflumilast for behandlingen av diabetes mellitus | |
| MX391921B (es) | Nepicastat para usarse en el tratamiento de dependencia | |
| CY1109191T1 (el) | Μια νεα χρηση της δεφεριπρονης | |
| EA201100755A1 (ru) | Способ лечения или профилактики тромбоза с использованием этексилата дабигатрана или его соли с улучшенной эффективностью по сравнению со стандартным лечением варфарином | |
| DK1809661T3 (da) | Humant interferon-beta-mutein | |
| EA200870091A1 (ru) | Применение бензоконденсированных гетероциклических сульфамидных производных для снятия боли | |
| ATE548035T1 (de) | Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat | |
| EA200870088A1 (ru) | Применение бензоконденсированных гетероциклических сульфамидных производных для понижения уровней липидов и глюкозы в крови | |
| EA200700407A1 (ru) | Производные хиназолина и их использования при лечении тромбоцитемии | |
| EP2754447A3 (de) | Behandlung von akutem nierenversagen mit löslichen thrombomodulin varianten | |
| CY1112438T1 (el) | Μεθοδος αγωγης της οξειας νεφρικης ανεπαρκειας με διαλυτη θρομβομοδουλινη | |
| ITMI20040954A1 (it) | Derivati del 3,6-diazabiciclo 3.1.i.eptano ad attivita' analgesica | |
| DE50111407D1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
| RU2007122391A (ru) | S-миртазапин для лечения приливов | |
| EA200702201A1 (ru) | Рофлумиласт для лечения лёгочной гипертензии | |
| ATE487485T1 (de) | Verwendung von d-ribose zur behandlung von vorhofflimmern | |
| TN2011000206A1 (en) | Compositions and methods of use soluble thrombomodulin variants | |
| DE602006020838D1 (de) | Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum | |
| ATE546137T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von warzen | |
| ATE454144T1 (de) | Behandlung von malignen neoplasien |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1948216 Country of ref document: EP |